Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aryeh Shander, Gregg P Lobel & Mazyar Javidroozi. (2016) Transfusion practices and infectious risks. Expert Review of Hematology 9:6, pages 597-605.
Read now
Read now
Articles from other publishers (22)
Aryeh Shander, Faraz Syed & Mazyar Javidroozi. 2018. Principles of Geriatric Critical Care. Principles of Geriatric Critical Care
147
167
.
Aryeh Shander, Mazyar Javidroozi & Gregg Lobel. (2017) Patient Blood Management in the Intensive Care Unit. Transfusion Medicine Reviews 31:4, pages 264-271.
Crossref
Crossref
Tahwinder Upile, Waseem Jerjes, Sandeep Singh, Mohammed Al-Khawalde, Zaid Hamdoon, Hani Radhi & Colin Hopper. (2012) The use of specific anti-growth factor antibodies to abrogate the oncological consequences of transfusion in head & neck squamous cell carcinoma: an in vitro study. Head & Neck Oncology 4:1.
Crossref
Crossref
M.A. GarcíaL. BautistaF. Palomino. (2012) Should blood donors be routinely screened for irregular antibodies?. Immunohematology 28:2, pages 60-66.
Crossref
Crossref
Tahwinder Upile, Waseem Jerjes, Jaspal Mahil, Navdeep Upile, Holger Sudhoff, Anthony Wright & Colin Hopper. (2011) An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products. European Archives of Oto-Rhino-Laryngology 268:12, pages 1789-1794.
Crossref
Crossref
Joan Cid, Gloria Carbassé, Arturo Pereira, Cristina Sanz, Roberto Mazzara, Ginés Escolar & Miguel Lozano. (2011) Platelet transfusions from D+ donors to D− patients: a 10-year follow-up study of 1014 patients. Transfusion 51:6, pages 1163-1169.
Crossref
Crossref
Antonino Amato & Mario Pescatori. (2006) Perioperative blood transfusions and recurrence of colorectal cancer. Cochrane Database of Systematic Reviews 2011:2.
Crossref
Crossref
Girolamo A. Ortolano, Rosalind L. Russell, Judy A. Angelbeck, Jeffrey Schaffer & Barry Wenz. (2004) Contamination Control in Nursing With Filtration. Journal of Infusion Nursing 27:3, pages 157-165.
Crossref
Crossref
Bela BalintJ.J.. (2003) Nepovoljni efekti hemoterapije i njihovo spre?avanje. Vojnosanitetski pregled 60:2, pages 185-194.
Crossref
Crossref
Andreas E. Biedler, Sven O. Schneider, Ullrich Seyfert, Hauke Rensing, Sasha Grenner, Matthias Girndt, Inge Bauer & Michael Bauer. (2002) Impact of Alloantigens and Storage-associated Factors on Stimulated Cytokine Response in an In Vitro Model of Blood Transfusion. Anesthesiology 97:5, pages 1102-1109.
Crossref
Crossref
Manuel Muñoz Gómez, Juan Vicente Llau Pitarch, Santiago Ramón Leal Noval, José Antonio García Erce & Jesús Manuel Culebras Fernández. (2002) Transfusión sanguínea perioperatoria en el paciente neoplásico. I. Alteraciones inmunológicas y consecuencias clínicas. Cirugía Española 72:3, pages 160-168.
Crossref
Crossref
Eleftherios C. Vamvakas & Morris A. Blajchman. (2002) Universal WBC reduction:the case for and against. Transfusion 41:5, pages 691-712.
Crossref
Crossref
Hong Chang, Michael Voralia, Meenakshi Bali, Graham D. Sher & Donald R. Branch. (2008) Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion‐associated graft‐versus‐host disease from stored blood. British Journal of Haematology 111:1, pages 146-156.
Crossref
Crossref
E. Fiebig, D.F. Hirschkorn, V.C. Maino, J.A. Grass, L. Lin & M.P. Busch. (2002) Assessment of donor T‐cell function in cellular blood components by the CD69 induction assay: effects of storage, γ radiation, and photochemical treatment. Transfusion 40:7, pages 761-770.
Crossref
Crossref
Eleftherios C. Vamvakas & Morris A. Blajchman. (2000) Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Transfusion Medicine Reviews 14:1, pages 23-33.
Crossref
Crossref
P. Innerhofer, G. Luz, L. Spötl, P. Hobisch‐Hagen, W. Schobersberger, M. Fischer, W. Nussbaumer, A. Lochs & E. Irschick. (2002) Immunologic changes after transfusion of autologous or allogeneic buffy coat‐poor versus white cell‐reduced blood to patients undergoing arthroplasty. I. Proliferative T‐cell responses and the balance of helper and suppressor T cells. Transfusion 39:10, pages 1089-1096.
Crossref
Crossref
A.C. Amato. (1999) Are allogenic blood transfusions acceptable in elective surgery in colorectal carcinoma?. European Journal of Cancer 35:3, pages 358-360.
Crossref
Crossref
M. Mincheff. (2011) Changes in Donor Leukocytes during Blood Storage. Implications on Post‐ Transfusion Immunomodulation and Transfusion‐Associated GVHD. Vox Sanguinis 74:S2, pages 189-200.
Crossref
Crossref
B Rau, P.M Schlag, F Willeke, Ch Herfarth, P Stephan & W Franke. (1998) Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO). European Journal of Cancer 34:7, pages 992-998.
Crossref
Crossref
F. Robert Purdy, Martin G. Tweeddale & Pamela M. Merrick. (1997) Association of mortality with age of blood transfused in septic ICU patients. Canadian Journal of Anaesthesia 44:12, pages 1256-1261.
Crossref
Crossref
Sean P Lyden, Joe H PattonJr.Jr., George E Woodman, D.Nicholas Ragsdale, Adam P Willis, Timothy C Fabian & Kenneth G Proctor. (1997) Effect of transfusion on physiologic changes after resuscitated trauma. Surgery 122:3, pages 534-545.
Crossref
Crossref
Barbara J. van der Mast, Henk E. Vi??tor, Ellen M.W. van der Meer-Prins, Simone P.M.J. van Bree, Anneke Brand, Peter J. van den Elsen & Frans H.J. Claas. (1997) MODULATION OF THE T CELL COMPARTMENT BY BLOOD TRANSFUSION. Transplantation 63:8, pages 1145-1154.
Crossref
Crossref